A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?

In March 2020, the first pandemic caused by a coronavirus was declared by the World Health Organization. Italy was one of the first and most severely affected countries, particularly the northern part of the country. The latest evidence suggests that the virus could have been circulating, at least i...

Full description

Bibliographic Details
Main Authors: Claudia Maria Trombetta, Serena Marchi, Simonetta Viviani, Alessandro Manenti, Elisa Casa, Francesca Dapporto, Edmond J. Remarque, Valentina Bollati, Ilaria Manini, Giacomo Lazzeri, Emanuele Montomoli
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2047582
_version_ 1827806457931759616
author Claudia Maria Trombetta
Serena Marchi
Simonetta Viviani
Alessandro Manenti
Elisa Casa
Francesca Dapporto
Edmond J. Remarque
Valentina Bollati
Ilaria Manini
Giacomo Lazzeri
Emanuele Montomoli
author_facet Claudia Maria Trombetta
Serena Marchi
Simonetta Viviani
Alessandro Manenti
Elisa Casa
Francesca Dapporto
Edmond J. Remarque
Valentina Bollati
Ilaria Manini
Giacomo Lazzeri
Emanuele Montomoli
author_sort Claudia Maria Trombetta
collection DOAJ
description In March 2020, the first pandemic caused by a coronavirus was declared by the World Health Organization. Italy was one of the first and most severely affected countries, particularly the northern part of the country. The latest evidence suggests that the virus could have been circulating, at least in Italy, before the first autochthonous SARS-COV-2 case was detected in February 2020. The present study aimed to investigate the presence of antibodies against SARS-CoV-2 in human serum samples collected in the last months of 2019 (September–December) in the Apulia region, Southern Italy. Eight of 455 samples tested proved positive on in-house receptor-binding-domain-based ELISA. Given the month of collection of the positive samples, these findings may indicate early circulation of SARS-CoV-2 in Apulia region in the autumn of 2019. However, it cannot be completely ruled out that the observed sero-reactivity could be an unknown antigen specificity in another virus to which subjects were exposed containing an epitope adventitiously cross-reactive with an epitope of SARS-CoV-2.
first_indexed 2024-03-11T21:41:26Z
format Article
id doaj.art-2afc0bde022b4916af4e61b239e5e9ef
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:41:26Z
publishDate 2022-11-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-2afc0bde022b4916af4e61b239e5e9ef2023-09-26T13:19:05ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20475822047582A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?Claudia Maria Trombetta0Serena Marchi1Simonetta Viviani2Alessandro Manenti3Elisa Casa4Francesca Dapporto5Edmond J. Remarque6Valentina Bollati7Ilaria Manini8Giacomo Lazzeri9Emanuele Montomoli10University of SienaUniversity of SienaUniversity of SienaVisMederi srlVisMederi Research srlVisMederi Research srlBiomedical Primate Research CentreUniversity of MilanUniversity of SienaUniversity of SienaUniversity of SienaIn March 2020, the first pandemic caused by a coronavirus was declared by the World Health Organization. Italy was one of the first and most severely affected countries, particularly the northern part of the country. The latest evidence suggests that the virus could have been circulating, at least in Italy, before the first autochthonous SARS-COV-2 case was detected in February 2020. The present study aimed to investigate the presence of antibodies against SARS-CoV-2 in human serum samples collected in the last months of 2019 (September–December) in the Apulia region, Southern Italy. Eight of 455 samples tested proved positive on in-house receptor-binding-domain-based ELISA. Given the month of collection of the positive samples, these findings may indicate early circulation of SARS-CoV-2 in Apulia region in the autumn of 2019. However, it cannot be completely ruled out that the observed sero-reactivity could be an unknown antigen specificity in another virus to which subjects were exposed containing an epitope adventitiously cross-reactive with an epitope of SARS-CoV-2.http://dx.doi.org/10.1080/21645515.2022.2047582sars-cov-2antibodies2019italy
spellingShingle Claudia Maria Trombetta
Serena Marchi
Simonetta Viviani
Alessandro Manenti
Elisa Casa
Francesca Dapporto
Edmond J. Remarque
Valentina Bollati
Ilaria Manini
Giacomo Lazzeri
Emanuele Montomoli
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
Human Vaccines & Immunotherapeutics
sars-cov-2
antibodies
2019
italy
title A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
title_full A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
title_fullStr A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
title_full_unstemmed A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
title_short A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
title_sort serological investigation in southern italy was sars cov 2 circulating in late 2019
topic sars-cov-2
antibodies
2019
italy
url http://dx.doi.org/10.1080/21645515.2022.2047582
work_keys_str_mv AT claudiamariatrombetta aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT serenamarchi aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT simonettaviviani aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT alessandromanenti aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT elisacasa aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT francescadapporto aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT edmondjremarque aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT valentinabollati aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT ilariamanini aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT giacomolazzeri aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT emanuelemontomoli aserologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT claudiamariatrombetta serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT serenamarchi serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT simonettaviviani serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT alessandromanenti serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT elisacasa serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT francescadapporto serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT edmondjremarque serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT valentinabollati serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT ilariamanini serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT giacomolazzeri serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019
AT emanuelemontomoli serologicalinvestigationinsouthernitalywassarscov2circulatinginlate2019